Phase II Study of Nanoparticle Albumin-bound Paclitaxel Plus Gemcitabine as First-line Therapy for the Treatment of Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma
Phase of Trial: Phase II
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Bladder cancer; Urethral cancer
- Focus Therapeutic Use
- 23 Jan 2017 Planned End Date changed from 1 Oct 2019 to 30 Dec 2019.
- 23 Jan 2017 Planned primary completion date changed from 1 Sep 2018 to 20 Dec 2018.
- 23 Jan 2017 Status changed from not yet recruiting to recruiting.